
Ophthalmic New Drug Developer

Contact Lens Manufacturer
Santen Pharmaceutical Co., Ltd. and Menicon Co., Ltd. Strategic Cooperation Agreement Signing CeremonyThis collaboration with Menicon will further enhance Calseno.® Accessibility.As a global leading brand of contact lenses, Menicon has an extensive distribution network and marketing capabilities in China.After the cooperation, Santen Pharmaceutical will continue to leverage its advantages in product development, brand building, and market promotion, while combining Menicon's strengths in market insights, market access, and channel development accumulated over the years in China's contact lens market, to help expand the application of Careyno® and benefit a wide range of users.Consumers of contact lenses。
Santen Pharmaceutical Co., Ltd. and Menicon Co., Ltd. Officially Establish Strategic PartnershipTakayuki Yamada, President of Santen Pharmaceutical ChinaStated: "Focusing on the actual needs of the vast number of Chinese consumers and providing more consumers with higher-quality eye care products is the core driving factor for both parties to quickly reach a strategic cooperation. The collaboration with Menicon achieves complementary advantages, allowing more consumers to benefit."
Menicon China General Manager Sun Zhengji"As a contact lens company focusing on visual health, Menicon has always adhered to innovation-driven development, committed to bringing better vision and visual experience to users worldwide. The achievement of this strategic cooperation will also promote the optimal allocation of resources, enhance market competitiveness, and thereby provide contact lens consumers with higher-quality care products."
About Santen
Santen Pharmaceutical focuses on the ophthalmology field, primarily engaging in the research and development, marketing, and sales of pharmaceuticals, over-the-counter products, and medical devices. Its products have now reached patients in more than 60 countries and regions.
Santen is committed to ultimately realizing its "World Vision" (Happiness with Vision). As an "innovator in society," Santen reduces social and economic losses caused by eye diseases or discomfort worldwide by integrating key technologies and strengths from around the world.
Santen Pharmaceutical Co., Ltd. has over 130 years of history, possessing extensive scientific knowledge and strong organizational capabilities. It is committed to providing products and services that improve the health and well-being of patients and those who care for them, thereby contributing to society.
For more information, please visit the website of Santen Pharmaceutical Co., Ltd.:http://www.santen-china.cn/
About Menicon
Menicon, established in 1951, is a comprehensive vision care company integrating the research and development, manufacturing, and sales of contact lenses. Guided by the corporate spirit of "Creation, Originality, and Challenge," it provides one-stop, full-lifecycle vision solutions catering to different populations and various vision needs. Today, Menicon has developed a diversified product portfolio including myopia prevention and control products, RGP contact lenses, rigid lens care systems, and soft contact lenses. Its products are sold in more than 80 countries and regions worldwide, making it a leader in the rigid contact lens industry. Since entering the Chinese market in 2005, Menicon has deeply cultivated its presence in China. Its products are popular across more than 30 provinces and cities in China and have established strong, long-term strategic partnerships with over a thousand professional institutions, including global ophthalmology chains, large general hospitals across China, and optometry clinics. The company has earned widespread acclaim from professionals in the optometry field, and its products have gained the trust of a broad patient base.
About Contact Lens Lubricant Kaysno®
Kai Shi Nuo® Contact Lens Lubricant is the first medical device product in China by Santen Pharmaceutical as the marketing authorization holder. Kai Shi Nuo® is a nano-emulsion that mimics the composition of the tear film, usable before and after wearing contact lenses, as well as during wear, enhancing the convenience of lens handling and comfort while wearing. Kai Shi Nuo® incorporates the innovative Novasorb technology platform, delivering nano oil droplets to the ocular surface to increase the thickness of the tear film lipid layer. Additionally, the positive charge in the lubricant can create electrostatic attraction with the negatively charged ocular surface, increasing the coverage area on the ocular surface and prolonging its effect. Kai Shi Nuo® comes in single-use packaging, is preservative-free, further enhancing safety for long-term use.